New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths

Go back to New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths
HAEMONETICS CORPORATION (NYSE: HAE) Delayed: 116.16 -0.95 (0.81%)
Previous Close $117.11    52 Week High $39.41 
Open $117.70    52 Week Low $25.98 
Day High $118.68    P/E 163.61 
Day Low $116.07    EPS $0.71 
Volume 365,126